GILD

Gilead Sciences, Inc. News Headlines

$103.96
*  
1.69
1.65%
Get GILD Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
8/22/2014 5:55:00 PM - Zacks.com

Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog
8/22/2014 5:35:00 PM - Zacks.com

3 Reasons Bristol-Myers Squibb's Stock Could Rise
8/22/2014 4:47:28 PM - Motley Fool

Amgen Upgraded to Strong Buy - Analyst Blog
8/22/2014 4:40:00 PM - Zacks.com

Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% - Tale of the Tape
8/22/2014 9:39:00 AM - Zacks.com

Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again - Tale of the Tape
8/22/2014 8:49:00 AM - Zacks.com

Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha

Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog
8/21/2014 5:20:00 PM - Zacks.com

Achillion Attains 52-Week High on ACH-3102 Patent Protection - Analyst Blog
8/21/2014 5:00:00 PM - Zacks.com

Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog
8/21/2014 4:55:00 PM - Zacks.com

Nasdaq 100 Movers: SPLS, GILD
8/21/2014 11:58:21 AM - BNK Invest

Jim Cramer's Stop Trading: Don't Worry About Gilead Sciences
8/21/2014 11:10:00 AM - TheStreet

VTI, MRK, KO, GILD: Large Inflows Detected at ETF
8/21/2014 10:49:53 AM - BNK Invest

Gilead (GILD) Hits 52-Week High Thanks to Sovaldi - Analyst Blog
8/21/2014 9:56:00 AM - Zacks.com

Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape
8/21/2014 9:39:00 AM - Zacks.com

Discovery Laboratories (DSCO) Worth Watching: Stock Up 6.9% - Tale of the Tape
8/21/2014 9:25:00 AM - Zacks.com

Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog
8/20/2014 6:08:00 PM - Zacks.com

3 Reasons Gilead Science, Inc.’s Stock Could Rise
8/20/2014 5:36:21 PM - Motley Fool

Hospira Sues FDA on Generic Precedex Approval, Shares Down - Analyst Blog
8/20/2014 5:00:00 PM - Zacks.com

Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
8/20/2014 4:27:00 PM - Zacks.com

Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
8/20/2014 3:53:00 PM - Zacks.com

Determining Gilead's Fair Value
8/20/2014 2:51:00 PM - Seeking Alpha

Record Earnings & Stronger Growth in Q2 - Earnings Outlook
8/20/2014 3:57:00 AM - Zacks.com

Record Earnings & Stronger Growth in Q2 - Earnings Trends
8/20/2014 3:57:00 AM - Zacks.com

Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
8/19/2014 5:55:00 PM - Zacks.com